Medicine and Dentistry
Neoplasm
100%
Surgical Margin
53%
Cetuximab
47%
Molecular Imaging
38%
Oral Cancer
36%
Lymph Node
36%
Mouth Squamous Cell Carcinoma
34%
Solid Malignant Neoplasm
26%
Ex Vivo
26%
Imaging Agent
24%
Head and Neck Cancer
22%
Epidermal Growth Factor Receptor
21%
Head and Neck Squamous Cell Carcinoma
20%
Malignant Neoplasm
19%
Surgery
18%
Imaging Technique
16%
Endoscopy
15%
Lymph Node Metastasis
13%
Optical Imaging
12%
Radioactive Tracer
11%
Histopathology
11%
Cancer Surgery
11%
Clinical Method
10%
Clinical Trial
10%
Clinical Decision Making
9%
Metastatic Carcinoma
9%
Vasculotropin A
8%
Sentinel Lymph Node Biopsy
8%
Neck Cancer Surgery
8%
Surgeon
7%
Narrow Band Imaging
7%
Phase II Trials
7%
Soft Tissue Sarcoma
7%
Colorectal Polyp
7%
Image-Guided Surgery
7%
Contrast Medium
7%
Barrett Esophagus
7%
Cancer Therapy
7%
Biopsy
7%
Inverted Papilloma
7%
Penis Carcinoma
7%
Photoacoustic Tomography
7%
Metabolic Acidosis
7%
Cancer Diagnosis
7%
Acidosis
7%
Micrometastasis
7%
Infrared Imaging
7%
Optical Tomography
7%
Surgery
7%
Primary Tumor
7%
Keyphrases
Fluorescence Imaging
24%
Tumor
14%
Fluorescence Molecular Imaging
14%
Oral Cancer
12%
Cancer Treatment
8%
Mesoscopic Imaging
7%
Receptor Targets
7%
Epidermal Growth Factor Receptor
7%
Phase I Study
7%
Histopathological Examination
7%
Cetuximab
7%
Solid Cancer
7%
Oral Cavity Cancer
7%
Dual Aperture
7%
Near-infrared Fluorescence Imaging
7%
Surgical Accuracy
7%
Imaging Window
7%
Barrett's Esophagus
7%
Fluorescence Endoscopy
7%
Guided Visualization
7%
C-Met
7%
Benign Lymph Node
7%
Targeted Contrast Agent
7%
EGFR-targeting
7%
Clinical Application
7%
Tumor-agnostic
7%
Activatable Nanoprobes
7%
Sinonasal Inverted Papilloma
7%
Grid Analysis
7%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
7%
Metastasis
7%
Lymph Node Sampling
7%
Cancer Diagnosis
7%
Heterogenous Media
7%
Variable Aperture
7%
Paired-agent Imaging
7%
Status Assessment
7%
Ratiometric
7%
Margin Status
7%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
7%
Angular Domain
7%
Imaging Approach
7%
Clinical Tumor Samples
7%
Paired-agent
7%
Dilution Ratio
7%
Imaging Interval
6%
Fluorescent Tracer
5%